Table 2

Overview of supplied instructions

Working compound and dosageBrand nameManufacturerNumber
of different marketing authorisation holders
Steps
ShakingDust capNose blowingHand position
A
Hand position
B
Closing nostril
A
Closing nostril
B
Head position
A
Head position
B
Position sprayInhalation
A
Inhalation
B
ExhalationClean nozzle
A
Clean nozzle
B
Dust capStorage
1Beclomethasone 50 µg-Mylan16
2Beclomethasone 50 µgBeconaseOmega-
3Beclomethasone 50 µgBeconaseGSK-
4Beclomethasone 50 µgNasobecTeva-
5Beclomethasone 50 µgHayfever reliefAyrton Saunders9
6Beclomethasone 50 µgPollenaseAyrton Saunders-
7Beclomethasone 50 µg-Ennogen Pharma-
8Budesonide 64 µg-Sandoz4
9Budesonide 64 µgRhinocortAstrazeneca4
10Budesonide 64 µgBenacortAstrazeneca-
11Fluticasone furoate 50 µgPirinase hayfever reliefGSK-
12Fluticasone furoate 50 µgHayfever and allergyGSK-
13Fluticasone furoate 50 µgFlixonaseGSK7
14Fluticasone furoate 50 µgNasofanTeva11
15Fluticasone furoate 50 µgFlunaseTeva-
16Azelastine 125 µg
Fluticasone propionate 50 µg
DymistaMeda Pharma-
17Fluticasone proprionate 27.5 µgAvamysGSK-
18Mometasone furoate 50 µg-Teva-
19Mometasone furoate 50 µg-Sandoz-
20Mometasone furoate 50 µg-Schering-Plough Labo10
21Mometasone furoate 50 µg-Cipla-
  • Listed are the included INCS. Indicated is the working compound and dosage, the brand name if present, the manufacturer and the number of marketing authorisation holders if present. Also, illustrated is an overview of the consecutive steps for use of INCS as described in table 1. For each spray is indicated whether a specific step is supplied in the PIL , if supplied than the box is ticked with ✓.